BSE Sensex gains 61 points ahead of RBI policy review
.jpg)
The benchmark BSE Sensex gained over 61 points in early trade today on sustained and selective buying by funds and retail investors ahead of RBI's policy meet.
Continuing yesterday's winning streak, the 30-share index rose further by 61.03 points, or 0.24 per cent, to 25,784.19, with all the sectoral indices, led by auto and banking, trading in positive zone with gains up to 0.62 per cent.
The Sensex had gained over 242.32 points in the previous session.
Experts believe markets could turn volatile after RBI governor Raghuram Rajan presents the monetary policy. "Indian markets are likely to open positive following the positive Asian markets but may turn volatile as RBI announces its monetary policy review. Nifty may correct further from the current level and it may touch 7500 in the near term. Key near term support is at 7450. Resistance is at 7700.However, the Nifty is likely to consolidate within a range of 7500 – 7800," Standard Chartered Securities said in its morning note
The National Stock Exchange index Nifty rose 13.95 points, or 0.18 per cent, to 7,697.60 in early trade.
Brokers said selective buying by cautious funds and retail investors ahead of RBI's bi-monthly policy review later in the day influenced the trading sentiments.
Technology stocks and defensives such as healthcare leading gains.
Infosys Ltd gains 1.1 percent, adding to its 3.7 percent gain on Monday. Sun Pharmaceuticals Industries is up 1.7 percent, while Dr Reddy's Laboratories gains 0.6 percent.
Infosys Ltd gains 1.1 percent, adding to its 3.7 percent gain on Monday. Sun Pharmaceuticals Industries is up 1.7 percent, while Dr Reddy's Laboratories gains 0.6 percent.
The US Dow Jones Industrial Average ended 0.46 per cent higher in yesterday's trade.
Other Latest News
.webp)
AAP supremo Arvind Kejriwal on Thursday intensified his criticism of the BJP-led central government, accusing it of failing to ensure law and order in Delhi.
Addressing a press conference at party office, Kejriwal said, "There is an atmosphere of fear and insecurity everywhere in Delhi. Women feel unsafe stepping out after 7 pm and parents worry about their daughters going outside."
.webp)
The High Court on Thursday refused to ban ISKCON's activities in Bangladesh, a local newspaper reported days after a lawyer was killed in a clash between security personnel and supporters of a Hindu leader arrested on sedition charges.
The lawyer had sought a ban from the high court on the International Society for Krishna Consciousness (ISKCON) after placing some newspaper reports related to the organisation on Wednesday.
.webp)
The Manipur government on Thursday announced that classes in schools and colleges in Imphal Valley districts and Jiribam would resume from November 28 after a hiatus of 13 days.
Educational institutes in these districts have remained closed since November 16 after the dead bodies of three women and three children in Jiribam were recovered from the Jiri and Barak rivers in Manipur and Assam respectively.
.webp)
Eknath Shinde, who served as chief minister in the outgoing Maharashtra government, is unlikely to accept the post of deputy CM in the new dispensation, his close aide Sanjay Shirsat said on Thursday.
Shirsat, an MLA and spokesperson of the Shiv Sena, however, said Shinde would be a part of the cabinet.
.webp)
Dr. Reddy’s announced the launch of Toripalimab in India on Thursday, for patients diagnosed with nasopharyngeal carcinoma (NPC), a rare form of head and neck cancer.
Toripalimab, a New Biological Entity (NBE), is the only immuno-oncology drug approved by regulatory authorities like the USFDA, EMA, and MHRA for treating adults with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). It is globally recognised for its efficacy in this indication, the Hyderabad-based company said in a statement.
.webp)
.webp)
.webp)
.webp)
.webp)
